FIGS (FIGS) 주식 개요
는 자회사인 FIGS Canada, Inc.와 함께 미국 및 전 세계에서 소비자 직접 판매 헬스케어 의류 및 라이프스타일 회사로 운영되고 있습니다. 자세히 보기
FIGS Community Fair Values
Create NarrativeSee what 41 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
FIGS, Inc. 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | US$12.90 |
| 52주 최고가 | US$17.48 |
| 52주 최저가 | US$6.50 |
| 베타 | 1.07 |
| 1개월 변동 | -9.92% |
| 3개월 변동 | 4.79% |
| 1년 변동 | 76.95% |
| 3년 변동 | 133.27% |
| 5년 변동 | -65.83% |
| IPO 이후 변동 | -57.03% |
최근 뉴스 및 업데이트
내러티브 업데이트 • Aug 23
FIGS: International Expansion And Margin Strength Are Expected To Drive Future Upside
Analysts have raised the FIGS fair value estimate by $1.00 to $18.63, reflecting a mix of higher long term P/E assumptions and recent price target revisions around $16 to $22 that balance strong recent results with concerns about macro uncertainty and supply chain risks. Analyst Commentary Recent research on FIGS shows a mix of optimism about execution and growth, alongside concern about external risks and how much is already reflected in the stock price.
내러티브 업데이트 • Aug 07
FIGS: Future Returns Will Reflect Balanced Execution Strength And External Risk
For FIGS, the updated analyst fair value estimate has moved from $14.00 to $15.00 per share. This reflects recent Street price target revisions around $16.00 to $22.00 that are based on strong quarterly results but tempered by global macro and supply chain risks.Recent updates
내러티브 업데이트 • Aug 23
FIGS: International Expansion And Margin Strength Are Expected To Drive Future Upside
Analysts have raised the FIGS fair value estimate by $1.00 to $18.63, reflecting a mix of higher long term P/E assumptions and recent price target revisions around $16 to $22 that balance strong recent results with concerns about macro uncertainty and supply chain risks. Analyst Commentary Recent research on FIGS shows a mix of optimism about execution and growth, alongside concern about external risks and how much is already reflected in the stock price.내러티브 업데이트 • Aug 07
FIGS: Future Returns Will Reflect Balanced Execution Strength And External Risk
For FIGS, the updated analyst fair value estimate has moved from $14.00 to $15.00 per share. This reflects recent Street price target revisions around $16.00 to $22.00 that are based on strong quarterly results but tempered by global macro and supply chain risks.Seeking Alpha • Aug 02
FIGS Makes For A Better Fit Now (Rating Upgrade)
Summary FIGS, Inc. is upgraded from ‘sell’ to ‘hold’ as valuation now reflects fair value after a 16% share price decline and continued growth. FIGS delivered 28% YoY revenue growth in Q1 2026, driven by a 12% increase in active customers and higher net revenue per customer. Management guides for 14–16% revenue growth and a 27.7% EBITDA increase in 2026, supported by a strong net cash position of $277 million. While industry headwinds and economic uncertainty persist, FIGS’ diversified channels and international expansion underpin cautious optimism for continued performance. Read the full article on Seeking Alpha내러티브 업데이트 • Jul 08
FIGS: Higher Profitability Assumptions Will Support Stronger Future Share Performance
The fair value estimate for FIGS has been raised from $6.20 to $14.00. This change reflects analysts' updated assumptions for higher revenue growth, stronger profit margins, and a richer future P/E multiple.
내러티브 업데이트 • Jun 24
FIGS: Execution And 2026 Outlook Are Expected To Sustain Upside Potential
Analysts raised their price target on FIGS by a few dollars into the low to mid $20s, citing steadier growth and profitability assumptions. These revisions leave the stock trading on a slightly lower implied future P/E multiple, even though fair value estimates remain essentially unchanged.내러티브 업데이트 • Jun 09
FIGS: International Expansion And 2026 Outlook Are Expected To Sustain Upside Potential
Analysts maintained FIGS' fair value estimate at $22.00, making modest adjustments to underlying assumptions such as a slightly lower discount rate and updated margin and growth inputs. These changes reflect refreshed research that incorporates recent price target increases from firms covering the stock.내러티브 업데이트 • May 26
FIGS: International Expansion And Margin Recovery Will Support Future Upside Potential
Analysts have inched their FIGS fair value estimate down from $17.75 to $17.63, reflecting a slightly higher discount rate and lower future P/E assumptions, even as they continue to cite international expansion, product initiatives, and scale potential as key support for higher Street price targets in the stock around $17 to $20. Analyst Commentary Recent Street research on FIGS clusters around price targets in the mid-to-high teens, with several firms lifting targets as they reassess the company’s execution and growth opportunities.내러티브 업데이트 • May 09
FIGS: International Expansion And Margin Recovery Will Drive Future Upside Potential
FIGS' analyst fair value estimate has been raised from $16.31 to $17.75 as analysts point to higher price targets following Q4 results that exceeded expectations, perceived progress on profitable growth, and ongoing opportunities in areas such as international expansion and product initiatives. Analyst Commentary Recent research on FIGS points to a mix of optimism around growth drivers and discipline on profitability, alongside some caution about margins returning to prior levels.내러티브 업데이트 • Apr 21
FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential
Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.내러티브 업데이트 • Apr 07
FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential
Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.내러티브 업데이트 • Mar 24
FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside
Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.내러티브 업데이트 • Mar 09
FIGS: Q4 Execution And Specialty Retail Tailwinds Are Expected To Drive Upside
The analyst fair value estimate for FIGS has increased to $20.00 from $15.00, as analysts point to Q4 earnings strength, improved profitability assumptions, and confidence that the company’s platform can support higher long term revenue potential. Analyst Commentary Recent research on FIGS has turned more constructive, with several bullish analysts revising their fair value views higher after the latest Q4 print and updated outlook.내러티브 업데이트 • Feb 23
FIGS: Higher Multiple Assumptions Will Likely Limit Future Share Price Upside
Analysts have nudged their price expectations for FIGS higher, with a modest lift in fair value and future P/E assumptions helping to raise the average price target by about $0.50 as they factor in slightly stronger revenue growth and profit margin potential. Analyst Commentary Recent Street commentary around FIGS points to a mixed but generally constructive stance, with modest price target increases set against ongoing questions about execution and sector risks.내러티브 업데이트 • Feb 09
FIGS: Demand Uncertainty In Specialty Retail Will Constrain Future Share Performance
Analysts have raised their FIGS fair value estimate from about $4.00 to roughly $6.20 per share. This reflects updated assumptions for revenue growth, profit margins, and the future P/E multiple that are in line with recent price target increases from firms such as Morgan Stanley, Barclays, and Roth Capital.내러티브 업데이트 • Jan 25
FIGS: Raised Outlook Will Rely On Specialty Retail Tailwinds Into 2026
Narrative Update Analysts have inched up their price targets on FIGS into the high single digit to low double digit US$ range, citing recent research that points to more constructive views on specialty retail through 2026 and firm specific discussions that suggest ongoing business momentum. At the same time, our model keeps fair value steady at US$15.00, with slightly higher revenue growth, margin and future P/E assumptions.내러티브 업데이트 • Jan 09
FIGS: Upgraded Outlook Hinges On Strong Brand And Healthcare Apparel Demand
Analysts have lifted their FIGS fair value estimate from US$8.00 to US$15.00, reflecting updated assumptions for revenue growth, profit margins and future P/E, along with a series of recent price target increases from Barclays, Roth Capital, Morgan Stanley, Goldman Sachs and BTIG. Analyst Commentary Recent Street research around FIGS has leaned more constructive, with several bullish analysts lifting price targets and initiating positive coverage.내러티브 업데이트 • Dec 26
FIGS: Reduced Discounting Will Likely Cap Upside Despite Recent Business Momentum
Analysts have modestly lowered our FIGS fair value estimate to approximately $9.17 per share from about $9.53, even as they raise price targets into the mid single to low double digits. They cite stronger than expected post Q3 momentum, improving demand trends, and a richer future earnings multiple outlook, despite slightly softer long term growth and margin assumptions.내러티브 업데이트 • Dec 12
FIGS: Recent Momentum Will Likely Fade As Reduced Discounting Limits Upside
Our FIGS fair value estimate increases to $9.53 from $8.78 as analysts lift price targets following stronger than expected Q3 results, sustained business momentum signals, and a more constructive view on the brand's long term earnings power. Analyst Commentary Street research on FIGS has turned more constructive overall, with several firms lifting price targets and initiating positive coverage following the company’s strong Q3 performance and improving demand indicators.내러티브 업데이트 • Nov 27
FIGS: Share Price Will Likely Reflect Limited Upside Amid Market Caution
Analysts have raised their fair value estimate for FIGS from $7.74 to $8.78, citing stronger than expected business momentum, improved revenue growth expectations, and expanding profit margins. Analyst Commentary Recent research coverage of FIGS has provided a mix of constructive insights and measured caution as analysts adjust their expectations.내러티브 업데이트 • Nov 13
FIGS: Future Competitive Pressures Will Likely Limit Further Upside
FIGS’ analyst price target has increased from $6.74 to $7.74 per share. Analysts point to stronger revenue growth expectations and positive trends within the healthcare apparel sector, which support the revised outlook.분석 기사 • Nov 11
There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 28% Price Jump
The FIGS, Inc. ( NYSE:FIGS ) share price has done very well over the last month, posting an excellent gain of 28%. The...내러티브 업데이트 • Oct 30
FIGS: High Market Expectations May Limit Upside As Momentum Slows
Analysts have slightly reduced their price target for FIGS, lowering it from $6.74 to $6.74. The adjustment reflects steady business fundamentals and persistent confidence in the brand's strong positioning within the healthcare apparel market.내러티브 업데이트 • Oct 15
Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment. Analyst Commentary Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation.내러티브 업데이트 • Aug 08
Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.분석 기사 • Jun 30
There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 35% Price Jump
FIGS, Inc. ( NYSE:FIGS ) shareholders have had their patience rewarded with a 35% share price jump in the last month...분석 기사 • May 29
It Looks Like FIGS, Inc.'s (NYSE:FIGS) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights FIGS to hold its Annual General Meeting on 4th of June CEO Trina Spear's total compensation includes...분석 기사 • May 09
Subdued Growth No Barrier To FIGS, Inc. (NYSE:FIGS) With Shares Advancing 40%
Those holding FIGS, Inc. ( NYSE:FIGS ) shares would be relieved that the share price has rebounded 40% in the last...분석 기사 • May 03
Is Now The Time To Look At Buying FIGS, Inc. (NYSE:FIGS)?
FIGS, Inc. ( NYSE:FIGS ), might not be a large cap stock, but it led the NYSE gainers with a relatively large price...Seeking Alpha • Apr 24
FIGS, Inc.: Recommending A Hold Despite Tailwinds
Summary FIGS, Inc. is recommended as a “HOLD” due to subpar financial performance and limited upside potential, despite growth plans and strong social media presence. Expansion into untapped markets and new physical stores, particularly in Philadelphia, are key business drivers for FIGS’ future growth. Financial analysis reveals significant declines in EBITDA, net income, and free cash flow, with only a slight increase in net revenue. Tariff risks pose substantial threats to FIGS, potentially increasing production costs and affecting profit margins and demand. Read the full article on Seeking Alpha분석 기사 • Mar 06
FIGS' (NYSE:FIGS) Soft Earnings Don't Show The Whole Picture
The most recent earnings report from FIGS, Inc. ( NYSE:FIGS ) was disappointing for shareholders. While the headline...Seeking Alpha • Mar 06
Figs, Inc. - Slow Growth Is Still Growth
Summary Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO. Superior product quality and brand loyalty, coupled with strategic cash reserves, position Figs, Inc. for steady growth and revenue expansion. Read the full article on Seeking Alpha분석 기사 • Jan 30
Be Wary Of FIGS (NYSE:FIGS) And Its Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Seeking Alpha • Dec 12
FIGS: Enter A White Knight?
Summary FIGS, Inc. faces stagnating sales and plummeting earnings, with recent Q3/2024 revenues shrinking by 1.5% YoY and operating losses mounting. Private equity firm Story3 Capital Partners is rumored to have offered $6 a share for FIGS, causing a pre-market rally; investors should take advantage and sell their shares. FIGS' valuation may be attractive to Story3, trading at 1.2x Fwd EV/Sales, compared to 2.4x for Nike and 4.6x for Lululemon. Management's diversification efforts have failed; a focus on international DTC medical scrubs could be a winning strategy under new ownership. Read the full article on Seeking AlphaSeeking Alpha • Nov 13
FIGS Back To Q1 Prices, But The Name Is Still A Hold
Summary Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest. Despite a great product, Figs' lack of expense control and high valuation make it an unattractive investment at current prices. Read the full article on Seeking Alpha분석 기사 • Nov 10
The Price Is Right For FIGS, Inc. (NYSE:FIGS) Even After Diving 26%
FIGS, Inc. ( NYSE:FIGS ) shares have had a horrible month, losing 26% after a relatively good period beforehand. The...주주 수익률
| FIGS | US Luxury | US 시장 | |
|---|---|---|---|
| 7D | -2.7% | -1.0% | -1.1% |
| 1Y | 77.0% | -29.0% | 11.7% |
수익률 대 산업: FIGS은 지난 1년 동안 -29%의 수익을 기록한 US Luxury 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: FIGS은 지난 1년 동안 11.7%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.
주가 변동성
| FIGS volatility | |
|---|---|
| FIGS Average Weekly Movement | 10.5% |
| Luxury Industry Average Movement | 6.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.9% |
안정적인 주가: FIGS의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.
시간에 따른 변동성: FIGS의 주간 변동성(11%)은 지난 1년 동안 안정적이었지만 US 종목 중 상위 75%보다 높습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 2013 | 359 | Trina Spear | www.wearfigs.com |
는 자회사인 FIGS Canada, Inc.와 함께 미국 및 전 세계에서 소비자 직접 판매 헬스케어 의류 및 라이프스타일 회사로 운영되고 있습니다. 이 회사는 겉옷, 언더스크럽, 신발, 압박 양말, 실험실 가운, 라운지웨어 및 기타 의류와 같은 수술복 및 비수술복 제품을 디자인하고 판매합니다. 또한 스포츠 의류, 퍼포먼스 레깅스 및 상의, 매우 부드러운 피마면 상의, 조끼, 플리스, 재킷, 그리고 스크럽 캡, 랜야드, 배지 릴, 가방, 야구 모자, 비니 등으로 구성된 필수품도 제공합니다.
FIGS, Inc. 기초 지표 요약
| FIGS 기초 통계 | |
|---|---|
| 시가총액 | US$2.21b |
| 순이익 (TTM) | US$61.92m |
| 매출 (TTM) | US$710.08m |
34.6x
주가수익비율(P/E)3.0x
주가매출비율(P/S)FIGS는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| FIGS 손익계산서 (TTM) | |
|---|---|
| 매출 | US$710.08m |
| 매출원가 | US$220.79m |
| 총이익 | US$489.29m |
| 기타 비용 | US$427.37m |
| 순이익 | US$61.92m |
최근 보고된 실적
Jun 30, 2026
다음 실적 발표일
해당 없음
| 주당순이익(EPS) | 0.37 |
| 총이익률 | 68.91% |
| 순이익률 | 8.72% |
| 부채/자본 비율 | 0% |
FIGS의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/09/16 19:57 |
| 종가 | 2026/09/16 00:00 |
| 수익 | 2026/06/30 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
FIGS, Inc.는 14명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Adrienne Yih-Tennant | Barclays |
| Robert Drbul | BTIG |
| Brooke Roach | Goldman Sachs |